Dr. Janice Schwartz published White Paper and presented plenary lecture

Janice Schwartz, MD and colleagues published the White Paper entitled: Roadmap to 2030 for Drug Evaluation in Older Adults in Clinical Pharmacology & Therapeutics that highlights the need for inclusion of older adults with multi-morbidity and receiving polypharmacy and those over the age of 80 years in clinical trials of new drugs that will be submitted to the FDA for marketing approval.

Janice Schwartz, MD also presented a plenary lecture entitled: Drug Development in older adults: Past, PRESENT, and ? future for the Australian Deprescribing network annual meeting on 11/11/21.